MFIM
CSTL icon

Mesirow Financial Investment Management’s Castle Biosciences CSTL Stock Holding History

Mesirow Financial Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,431
Closed -$328K – 87
2023
Q1 		$328K Buy
+14,431
New +$353K 1.36% 28
2022
Q4 		– Sell
-7,967
Closed -$208K – 82
2022
Q3 		$208K Buy
+7,967
New +$223K 0.99% 61
2022
Q2 		– Sell
-7,985
Closed -$358K – 73
2022
Q1 		$358K Buy
7,985
+25
+0.3% +$1.03K 1.21% 49
2021
Q4 		$341K Hold
7,960
– – 0.98% 62
2021
Q3 		$529K Sell
7,960
-223
-3% -$15.7K 1.56% 18
2021
Q2 		$600K Buy
8,183
+34
+0.4% +$2.25K 1.53% 13
2021
Q1 		$558K Sell
8,149
-198
-2% -$14.9K 1.52% 15
2020
Q4 		$561K Buy
8,347
+41
+0.5% +$2.22K 1.77% 13
2020
Q3 		$427K Buy
8,306
+57
+0.7% +$2.54K 1.83% 9
2020
Q2 		$311K Buy
+8,249
New +$282K 1.46% 31
2020
Q1 		– Sell
-15,463
Closed -$531K – 69
2019
Q4 		$531K Buy
+15,463
New +$378K 2.24% 3

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mesirow Financial Investment Management's CSTL Position: Q2 2023 in Review

Mesirow Financial Investment Management sold out of Castle Biosciences (CSTL) in Q2 2023, closing a stake of 14,431 shares — an estimated $328K sold.

Mesirow Financial Investment Management first reported a position in CSTL in Q4 2019 and held it in 11 quarters. The position peaked at $600K in Q2 2021. 130 funds tracked by Wall St. Rank hold CSTL as of Q2 2023.

  • Mesirow Financial Investment Management reported no remaining Castle Biosciences position as of Q2 2023 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 14,431 Castle Biosciences shares in Q2 2023, an estimated $328K.
  • Mesirow Financial Investment Management first reported a position in Castle Biosciences in Q4 2019 and held it in 11 quarters.
  • Mesirow Financial Investment Management's Castle Biosciences position peaked at $600K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2023.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2023, filed 17 Jul 2023.